Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Older age and low testosterone increase the risk of kidney stones in men.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Alopecia patients have less GPER-1, which might affect hair loss.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Certain compounds from Panax ginseng can block proteins that affect hair growth, potentially helping treat hair loss.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

The method shows hair testosterone levels reflect those in saliva, but are affected by various factors and may indicate a risk for heart attack.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Older men with lower levels of available testosterone are more likely to be frail.

More research is needed to understand how testosterone is maintained in adult males.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Androgens, like testosterone, are crucial for early testicular descent in rats.

Testosterone increases seizure risk through its conversion to specific neurosteroids.